CIK: 0001542339
Total reported value
$250.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 44.64% | — | — | |
| 2 | ✓ | Stock-Other | 15.31% | — | — | ||
| 3 | TELA | Tela Bio INC | Stock-Other | 12.96% | -0.95% | +6.00% | |
| 4 | AXGN | Axogen INC | Stock-Other | 12.25% | — | -18.44% | |
| 5 | PSDVUSD | Eyepoint Pharmaceuticals INC | Stock-Other | 11.58% | — | — | |
| 6 | MNOV | Medicinova INC | Stock-Other | 3.08% | +0.14% | — | |
| 7 | ✓ | Gyre Therapeutics INC Com | Stock-Other | 0.18% | — | — | |
| 8 | ELGXEUR | Endologix INC | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVNCEUR | Revance Therapeutics INC | +4.6% | — | Unchanged |
| 2 | TELA | Tela Bio INC | +4.1% | +6.00% | Add |
| 3 | AXGN | Axogen INC | +1.2% | -18.44% | Trim |
| 4 | MNOV | Medicinova INC | +0.1% | — | Unchanged |
| 5 | ✓ | Gyre Therapeutics INC Com | -0.1% | — | Unchanged |
| 6 | ELGXEUR | Endologix INC | -0.1% | — | Unchanged |
| 7 | PSDVUSD | Eyepoint Pharmaceuticals INC | -4% | — | Unchanged |
| 8 | ✓ | -6% | — | Unchanged |